Assignee
GILEAD CALISTOGA LLC
US14 patents
Top patents by PatentIndex Score
US8865730B2Oct 21, 2014
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC25 citations91
US9029384B2May 12, 2015
Phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC10 citations83
US10414737B2Sep 17, 2019
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC5 citations82
US10059677B2Aug 28, 2018
Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof
GILEAD CALISTOGA LLC8 citations82
US10047060B2Aug 14, 2018
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC7 citations82
US9567337B2Feb 14, 2017
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC10 citations82
US9469643B2Oct 18, 2016
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC9 citations82
US9708327B2Jul 18, 2017
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC12 citations81
US10730879B2Aug 4, 2020
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC2 citations71
US9238070B2Jan 19, 2016
Therapies for hematologic malignancies
GILEAD CALISTOGA LLC3 citations71
US10442805B2Oct 15, 2019
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
GILEAD CALISTOGA LLC3 citations70
US10954199B2Mar 23, 2021
Process methods for phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC0 citations61
US9018221B2Apr 28, 2015
Phosphatidylinositol 3-kinase inhibitors
GILEAD CALISTOGA LLC3 citations60
US10154998B2Dec 18, 2018
Therapies for hematologic malignancies
GILEAD CALISTOGA LLC0 citations48